NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement
In Brief: Tom Hall Names CMMI VP For Clinical Affairs; Rabson, Fauci Names to Institute Of Medicine
Consensus Panel Say Surgery, Radiation Both Effective For Clinically Local Prostate Cancer
Bristol To Support Grants For Studies On Drug Resistance
DCT Board Approves Concept For BRMP Master Agreement
Trending Stories
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds
- By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panel
Ransohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists” - ASCO & The Conquer Cancer Foundation announce merit awards
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Benjamin Ebert, Amy Gladfelter, Stephen Liberles, and Pardis Sabeti are among new members of the National Academy of Sciences









